150 related articles for article (PubMed ID: 32956923)
21. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
22. How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.
Spencer C; LoPresti J; Fatemi S
Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):394-404. PubMed ID: 25122493
[TBL] [Abstract][Full Text] [Related]
23. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer.
Jo K; Lim DJ
Korean J Intern Med; 2018 Nov; 33(6):1050-1057. PubMed ID: 30396251
[TBL] [Abstract][Full Text] [Related]
24. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.
Spencer C; Petrovic I; Fatemi S
J Clin Endocrinol Metab; 2011 May; 96(5):1283-91. PubMed ID: 21325460
[TBL] [Abstract][Full Text] [Related]
25. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
26. Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.
Cho YY; Chun S; Lee SY; Chung JH; Park HD; Kim SW
Ann Lab Med; 2016 Sep; 36(5):413-9. PubMed ID: 27374705
[TBL] [Abstract][Full Text] [Related]
27. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
Phan HT; Jager PL; van der Wal JE; Sluiter WJ; Plukker JT; Dierckx RA; Wolffenbuttel BH; Links TP
Eur J Endocrinol; 2008 Jan; 158(1):77-83. PubMed ID: 18166820
[TBL] [Abstract][Full Text] [Related]
28. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
[TBL] [Abstract][Full Text] [Related]
30. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
Spencer CA; Wang CC
Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
[TBL] [Abstract][Full Text] [Related]
31. Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.
Netzel BC; Grebe SK; Carranza Leon BG; Castro MR; Clark PM; Hoofnagle AN; Spencer CA; Turcu AF; Algeciras-Schimnich A
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1074-83. PubMed ID: 26079778
[TBL] [Abstract][Full Text] [Related]
32. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance.
Rosário PW; Maia FF; Fagundes TA; Vasconcelos FP; Cardoso LD; Purisch S
Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):487-92. PubMed ID: 15761511
[TBL] [Abstract][Full Text] [Related]
33. Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity.
Dekker BL; van der Horst-Schrivers ANA; Sluiter WJ; Brouwers AH; Lentjes EGWM; Heijboer AC; Muller Kobold AC; Links TP
Thyroid; 2019 Jan; 29(1):71-78. PubMed ID: 30351209
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
Giovanella L; Imperiali M; Verburg FA; Ceriani L
Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
[TBL] [Abstract][Full Text] [Related]
35. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas].
Tang GS; Xu J; Yu Y; Pan MZ; Wang JR; Yuan LP; Jiang T; Huang F; Jing CL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
[TBL] [Abstract][Full Text] [Related]
37. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
[TBL] [Abstract][Full Text] [Related]
38. Thyroglobulin antibodies in differentiated thyroid cancer.
Hjiyiannakis P; Mundy J; Harmer C
Clin Oncol (R Coll Radiol); 1999; 11(4):240-4. PubMed ID: 10473720
[TBL] [Abstract][Full Text] [Related]
39. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
40. Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery.
Okosieme OE; Evans C; Moss L; Parkes AB; Premawardhana LD; Lazarus JH
Clin Chem; 2005 Apr; 51(4):729-34. PubMed ID: 15695326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]